Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Health ministry bans...

    Health ministry bans sale of 14 steroid creams sans doctor’s prescription

    Written by Ruby Khatun Khatun Published On 2018-04-07T14:10:43+05:30  |  Updated On 7 April 2018 2:10 PM IST
    Health ministry bans sale of 14 steroid creams sans doctor’s prescription

    New Delhi: Through a recent gazette notification, Ministry of Health And Family Welfare has banned the over-the-counter (OTC) sale of 14 steroid-based creams and ointments by finally bringing them under the Schedule H of the Drugs and Cosmetic Rules, 1945. Now, it can be purchased from the chemists only after showing the doctor’s prescription.


    Schedule H is a class of prescription drugs in India appearing as an appendix to the Drugs and Cosmetics Rules, 1945 introduced in 1945. These are drugs which cannot be purchased over the counter without the prescription of a qualified doctor.


    The Union Ministry of Health has issued a notification as per the notification issued on March 23, 2018, bringing the 14 drugs under the Schedule H of the Drugs and Cosmetic Rules, 1945. These are




    • Alclometasone

    • Beclomethasone

    • Betamethasone

    • Desonide

    • Desoximetasone

    • Dexamethasone

    • Diflorasone diacetate

    • Fluocinonide

    • Fluocinolone acetonide

    • Halobetasol propionate

    • Halometasone

    • Methylprednisone

    • Prednicarbate

    • Triamcinolone acetonide.


    According to the notification, the decision to put the 14 drugs under Schedule H has been taken after consultation with the Drugs Technical Advisory Board.

    The notice states that whereas the draft of certain rules further to amend the Drugs and Cosmetics Rules, 1945 was published as required under sub-section(1) of section 12 and sub-section (1) of section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940) in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i) vide notification of the Government of India in the Ministry of Health and Family Welfare, Department of Health and Family Welfare, number G.S.R. 1357(E), dated the 1st November, 2017 inviting objections and suggestions from all persons likely to be affected thereby before the expiry of a period of forty-five days from the date on which copies of the Official Gazette containing the said notification were made available to the public;


    The notice further states that the copies of the said Official Gazette were made available to the public on 1st November, 2017 after that objections and suggestions were received from the public on the said rules which had been considered by the Central Government and therefore, in exercise of the powers conferred by section 12 and section 33 of the said Act, the Central Government, after consultation with the Drugs Technical Advisory Board, hereby makes the following rules further to amend the Drugs and Cosmetics Rules, 1945, namely,-


    (1) These rules may be called the Drugs and Cosmetics (Second Amendment) Rules, 2018.


    (2) They shall come into force on the date of their publication in the Official Gazette.


    Below is the attached notification
    doctorDrugs and Cosmetics RulesDrugs Technical Advisory BoardgovernmentMinistry of Health and Family WelfarePrescriptionSchedule Hschedule H drugssteroid products

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok